Reuters logo
BRIEF-Clearside Biomedical reports Q2 loss per share $0.54
August 9, 2017 / 11:34 AM / in 4 months

BRIEF-Clearside Biomedical reports Q2 loss per share $0.54

Aug 9 (Reuters) - Clearside Biomedical Inc

* Announces second quarter 2017 financial results and provides corporate update

* Q2 loss per share $0.54

* Q2 earnings per share view $-0.41 -- Thomson Reuters I/B/E/S

* Clearside biomedical - ‍cash, cash equivalents and short-term investments totaled $66.0 million as of june 30, compared to $83.6 million as of dec 31, 2016​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below